1Garber A J, Karlsson FO. Treatment of dyslipidemia in diabetes[J] .Endocrino and metab din North Am 2001 ;30:999-1010.
2American Diabetes Association. Management of dyslipidemia in adult with diabetes [J]. Diabetes Care 2002 ; 25 : S74-S77.
3Goldberg IJ. Diabetic dyslipidemia: cause and consequences[J] .J Clin Endocrinol Metab 2001;86(3) :965-71.
4Scadinavia Simvastatin Suvival Study Group. Randomized trial of cholesterol lowering in 4444 patient with coronary heart disease: the Scandinavia Simvastatin Suvival Study ( 4S ) [J].Lancet 1994;344:1383-1389.
5Gotto AM. Management of dyslipidemia[J]. AM J Med2002 ; 112 : 10s- 17s.
6Papadakis JA, MiUionis HJ. Treating dyslipidemia in noninsulin-dependent diabetes mellitus-a special reference to stations[J] .J Diabetes and its Complications 2001; 15:211-226.
7Knowler WC, Barrett-Connor E. Reduction in the indidence of type 2 diabetes with lifestyle intervention or metformin[J]. N Engl J Med 2002;346:393-403.
8Gotto AM. Lipid management in diabetic patient:lessons from prevention trials[J]. Am J Med 2002 ; 112:192-26s.
9Grundy SM, Kendall DM, Robertson DD, Efficacy, safety,and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes [J]. Arch Intern Med 2002 ; 162 : 1568- 1576.
10Grundy SM. Statin therapy in older persons [J]. Arch Intern Med 2002;162:1329-1331.
